Jonas Mattsson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL. 2024;75(3):621-630
Chest CT at X-Ray Dose Using a Noise-Mitigating Weighted Projection: The Thoracic Tomogram. Diagnostic Performance for Pneumonia Detection in Hemato-Oncology Patients.
Sanchez Tijmes F; Kandel S; Kavanagh J; Carey S; May M; Chen S; Mattsson J; Rogalla P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2024;30(7):681.e1-681.e11
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study.
Pasic I; Moya TA; Remberger M; Chen C; Gerbitz A; Kim DDH; Kumar R; Lam W; Law AD; Lipton JH; Michelis FV; Novitzky-Basso I; Viswabandya A; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2024;59(6):759-764
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease.
Murray A; Linn SM; Yu B; Novitzky-Basso I; Mattsson J; Kennah M; Elemary M; White J; Lemieux C; Jamani K; Kim DDH
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2024;30(5):536.e1-536.e13
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation.
Salas MQ; Alfaro-Moya T; Atenafu EG; Datt Law A; Lam W; Pasic I; Novitzky-Basso I; Santos Carreira A; Chen C; Michelis FV; Gerbitz A; Howard Lipton J; Kim DDH; Kumar R; Mattsson J; Viswabandya A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2024;30(5):520.e1-520.e12
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation.
Sayyed A; Chen C; Gerbitz A; Kim DDH; Kumar R; Lam W; Law AD; Lipton JH; Michelis FV; Novitzky-Basso I; Viswabandya A; Mattsson J; Pasic I
Article: BONE MARROW TRANSPLANTATION. 2024;59(4):534-540
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies.
Alfaro Moya T; Salas MQ; Santos Carreira A; Atenafu EG; Law AD; Lam W; Pasic I; Kim DDH; Michelis FV; Novitzky Basso I; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Article: ANNALS OF HEMATOLOGY. 2024;103(4):1187-1196
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.
Lucero J; Alhumaid M; Novitzky-Basso I; Capo-Chichi J-M; Stockley T; Gupta V; Bankar A; Chan S; Schuh AC; Minden M; Mattsson J; Kumar R; Sibai H; Tierens A; Kim DDH
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2024;22(1):273
CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude
Poiret T; Vikberg S; Schoutrop E; Mattsson J; Magalhaes I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2024;112(2):301-309
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Pang I; Chen P; Trinh GV; Remberger M; Novitzky-Basso I; Gerbitz A; Kim DD; Kumar R; Lam W; Law AD; Lipton JH; Viswabandya A; Pasic I; Mattsson J; Michelis FV
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(12):773.e1-773.e10
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD.
Novitzky-Basso I; Patriquin C; Linn SM; Chiarello C; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Barth D; Kim DDH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;111(5):687-696
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Novitzky-Basso I; Lam W; Chiarello C; Pasic I; Law AD; Michelis FV; Gerbitz A; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Messner HA; Marras TK; Mittoo S; Kim DDH
Article: BONE MARROW TRANSPLANTATION. 2023;58(11):1237-1246
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation.
Salas MQ; Atenafu EG; Pasic I; Bascom O; Wilson L; Lam W; Law AD; Chen C; Novitzky-Basso I; Kim DDH; Gerbitz A; Viswabandya A; Michelis FV; Lipton JH; Mattsson J; Alibhai SMH; Kumar R
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(11):697.e1-697.e10
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pereira MP; Remberger M; Chen C; Gerbitz A; Kim DDH; Kumar R; Lam W; Law AD; Lipton JH; Michelis FV; Novitzky-Basso I; Viswabandya A; Mattsson J; Pasic I
Article: LEUKEMIA RESEARCH. 2023;134:107387
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure.
Linn SM; Novitzky-Basso I; Patriquin C; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Barth D; Kim DDH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;111(4):553-561
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission
Moya TA; Mattsson J; Remberger M; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Gerbitz A; Pasic I; Novitzky-Basso I; Michelis FV
Article: SUPPORTIVE CARE IN CANCER. 2023;31(10):564
Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.
Madsen K; Lee K; Chen S; Chen C; Law AD; Gerbitz A; Kumar R; Kim D; Lam W; Pasic I; Viswabandya A; Michelis FV; Nampoothiri RV; Lipton JH; Novitzky-Basso I; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2023;58(9):1024-1032
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure.
Novitzky-Basso I; Linn SM; White J; Elemary M; Xenocostas A; Deotare U; Kelly K; Hamad N; Tan S; Culos S; Law A; Kumar R; Mattsson J; Kim DDH
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(9):581.e1-581.e8
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation
Carreira AS; Salas MQ; Remberger M; Novitzky-Basso I; Law AD; Lam W; Pasic I; Mazzulli T; Cserti-Gazdewich C; Kim DDH; Michelis FV; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Hassan M; Mattsson J
Article: HEMATOLOGY/ ONCOLOGY AND STEM CELL THERAPY. 2023;17(1):60-71
A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes.
Linn SM; Novitzky-Basso I; Abduljalil O; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Kim DDH
Article: HAEMATOLOGICA. 2023;108(7):1817-1826
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Kim KH; Kim T; Novitzky-Basso I; Lee H; Yoo Y; Ahn J-S; Pasic I; Law A; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Zhang Z; Kaushansky N; Brilon Y; Chapal-Ilani N; Biezuner T; Shlush LI; Kim DDH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(6):618-625
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Vasudevan Nampoothiri R; Tang K; Schuh A; Lam W; Maze D; Michelis FV; Chan S; Gupta V; Kim D; Kumar R; Lipton JH; Mattsson J; Minden M; Schimmer A; Sibai H; Viswabandya A; Yee K; Murphy T; Law AD
Article: TRANSFUSION AND APHERESIS SCIENCE. 2023;62(3):103705
Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
Schain F; Boissin C; Laczik T; Fedeli S; Remberger M; Blennow O; Dykes J; Eich T; Jones C; Mattsson J; Berlin G
Article: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023;61(6):1005-1014
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
Pasic I; Ren AH; Nampoothiri RV; Prassas I; Lipton JH; Mattsson J; Diamandis EP; Michelis FV
Article: HEMATOLOGY/ ONCOLOGY AND STEM CELL THERAPY. 2023;16(3):230-237
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center.
Linn SM; Nampoothiri RV; Chen C; Pasic I; Al-Shaibani Z; Lam W; Law AD; Michelis FV; Kim DDH; Gerbitz A; Lipton J; Kumar R; Mattsson J; Viswabandya A
Article: TIDSSKRIFT FOR DEN NORSKE LEGEFORENING. 2023;143(4)
Allogeneic stem cell transplantation in adults 2015-21.
Vo CD; Myhre AE; Abrahamsen IW; Remberger M; Mattsson J; Fløisand Y; Grønvold BCL; Tjønnfjord GE; Tvedt THA; Gedde-Dahl T
Article: BONE MARROW TRANSPLANTATION. 2023;58(3):317-324
Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults.
Salas MQ; Atenafu EG; Pasic I; Al-Shaibani E; Bascom O; Wilson L; Chen C; Law AD; Lam W; Novitzky-Basso I; Kim DDH; Gerbitz A; Viswabandya A; Michelis FV; Lipton JH; Mattsson J; Alibhai S; Kumar R
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023;11(2):e005691
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
Schoutrop E; Poiret T; El-Serafi I; Zhao Y; He R; Moter A; Henriksson J; Hassan M; Magalhaes I; Mattsson J
Article: PLOS ONE. 2023;18(5):e0285420
A longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT): Protocol for a phase II feasibility pilot randomized controlled trial.
Tam S; Kumar R; Lopez P; Mattsson J; Alibhai S; Atenafu EG; Bernstein LJ; Chang E; Clarke S; Langelier D; Lipton J; Mayo S; Papadakos T; Jones JM
Article: PLOS ONE. 2023;18(3):e0282753
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease
Novitzky-Basso I; Schain F; Batyrbekova N; Webb T; Remberger M; Keating A; Mattsson J
Article: ONCOIMMUNOLOGY. 2022;11(1):2093426
Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality
Schoutrop E; Renken S; Micallef Nilsson I; Hahn P; Poiret T; Kiessling R; Wickstrom SL; Mattsson J; Magalhaes I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):672-679
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups
Garcia-Horton A; Cyriac SL; Gedde-Dahl T; Floisand Y; Remberger M; Mattsson J; Michelis FV
Article: SEMINARS IN CANCER BIOLOGY. 2022;86(Pt 3):207-223
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Schoutrop E; Moyano-Galceran L; Lheureux S; Mattsson J; Lehti K; Dahlstrand H; Magalhaes I
Article: BONE MARROW TRANSPLANTATION. 2022;57(9):1411-1420
Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes.
Madsen K; Pelletier K; Côté G; Kitchlu A; Chen S; Mattsson J; Pasic I
Article: TRANSPLANT INFECTIOUS DISEASE. 2022;24(4):e13879
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation.
Prem S; Remberger M; Alotaibi A; Lam W; Law AD; Kim DDH; Michelis FV; Al-Shaibani Z; Lipton JH; Mattsson J; Viswabandya A; Kumar R; Ellison C
Article: EJHAEM. 2022;3(3):873-884
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.
Kim DDH; Novitzky Basso I; Kim TS; Yi SY; Kim KH; Murphy T; Chan S; Minden M; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Ng SWK; Stockley T; Zhang T; King I; Mattsson J; Wang JCY
Article: HAEMATOLOGICA. 2022;107(8):1786-1795
A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo
Arruda LCM; Stikvoort A; Lambert M; Jin L; Rivera LS; Alves RMP; de Moura TR; Mim C; Lehmann S; Axelsson-Robertson R; Dick JE; Mattsson J; Onfelt B; Carlsten M; Uhlin M
Article: CKJ: CLINICAL KIDNEY JOURNAL. 2022;15(8):1583-1592
Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant.
Pelletier K; Côté G; Madsen K; Chen S; Kim SJ; Chan CT; Mattsson J; Pasic I; Kitchlu A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2022;28(5):265.e1-265.e9
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Salas MQ; Pasic I; Remberger M; Novitzky-Basso I; Law AD; Lam W; Chen C; Kim DDH; Michelis FV; Gerbitz A; Viswabandya A; Lipton JH; Kumar R; Mattsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;108(5):430-436
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Vasudevan Nampoothiri R; Pasic I; Law AD; Lam W; Chen C; Michelis FV; Kim DDH; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Article: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2022;22(5):e327-e334
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients.
Al-Shaibani E; Bautista R; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;108(4):288-297
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors.
Novitzky-Basso I; Remberger M; Chen C; Ellison C; Pasic I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Michelis FV; Mattsson J
Article: HEMATOLOGY/ ONCOLOGY AND STEM CELL THERAPY. 2022;15(1):27-35
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Nampoothiri RV; Law AD; Lam W; Chen C; Al-Shaibani Z; Loach D; Michelis FV; Kim DDH; Mattsson J; Kumar R; Lipton JH; Viswabandya A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2022;28(1):50.e1-50.e8
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.
Carreira AS; Salas MQ; Remberger M; Basso IN; Law AD; Lam W; Pasic I; Kim D; Michelis FV; Viswabandya A; Gerbitz A; Lipton JH; Husain S; Kumar R; Mattsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;108(1):61-72
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV
Article: LEUKEMIA AND LYMPHOMA. 2021;62(14):3373-3383
Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections.
Salas MQ; Atenafu EG; Law AD; Lam W; Pasic I; Chen C; Kim DDH; Michelis FV; Gerbitz A; Lipton JH; Mattsson J; Kumar R; Viswabandya A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(5):517-528
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis.
Cyriac S; Prem S; Salas MQ; Chen S; Al-Shaibani Z; Lam W; Law A; Gupta V; Michelis FV; Kim DDH; Lipton J; Kumar R; Mattsson J; Viswabandya A
Article: BONE MARROW TRANSPLANTATION. 2021;56(10):2471-2476
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
Nampoothiri RV; Ho L; McEwan C; Pasic I; Lam W; Law AD; Michelis FV; Thyagu S; Kim DDH; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Kumar R
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(3):354-363
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
Novitzky-Basso I; Chen C; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law A; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
Article: BONE MARROW TRANSPLANTATION. 2021;56(8):1908-1918
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Daher-Reyes G; Kim T; Novitzky-Basso I; Kim KH; Smith A; Stockley T; Capochichi J-M; Al-Shaibani Z; Pasic I; Law A; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Schimmer A; McNamara C; Murphy T; Maze D; Gupta V; Sibai H; Chan S; Yee K; Minden M; Zhang Z; Schuh A; Kim DDH
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2021;27(7):600.e1-600.e8
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
Smith E; Huang J; Viswabandya A; Maze D; Malik S; Cheung V; Siddiq N; Claudio J; Arruda A; Kennedy J; Bankar A; Law AD; Lam W; Michelis FV; Kim D; Lipton J; Kumar R; Mattsson J; McNamara C; Sibai H; Xu W; Gupta V
Article: ORAL DISEASES. 2021;27(5):1217-1225
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis
Garming Legert K; Ringden O; Remberger M; Torlen J; Mattsson J; Dahllof G
Article: HEMATOLOGY/ ONCOLOGY AND STEM CELL THERAPY. 2021;14(2):134-140
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
Article: CANCER RESEARCH. 2021;81(11):3022-3035
Mesothelin-Specific CAR T Cells Target Ovarian Cancer
Schoutrop E; El-Serafi I; Poiret T; Zhao Y; Gultekin O; He R; Moyano-Galceran L; Carlson JW; Lehti K; Hassan M; Magalhaes I; Mattsson J
Article: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2021;21(6):e559-e568
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.
Al-Shaibani E; Cyriac S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law A; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2021;27(5):428.e1-428.e9
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.
Salas MQ; Atenafu EG; Law AD; Lam W; Pasic I; Chen C; Dong Hwan Kim D; Michelis FV; Gerbitz A; Lipton JH; Mattsson J; Kumar R; Viswabandya A
Article: ANNALS OF HEMATOLOGY. 2021;100(5):1311-1319
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
Law AD; Bhella S; Pasic I; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Kumar R; Lipton JH; Mattsson J; Kim DDH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):508-519
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Novitzky-Basso I; AlHayli S; Shin E; Pasic I; Al-Shaibani Z; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
Article: BONE MARROW TRANSPLANTATION. 2021;56(4):807-817
Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study
El-Serafi A; He R; Zheng W; Benkossou F; Oerther S; Zhao Y; Mellgren K; Gustafsson B; Heilmann C; Kanerva J; Lotfi K; Toporski J; Sundin M; Hoglund M; Mattsson J; El-Serafi I; Hassan M
Article: ANNALS OF HEMATOLOGY. 2021;100(3):789-798
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
Fingrut W; Law A; Lam W; Michelis FV; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(2):158-164
Prolactin, a potential biomarker for chronic GVHD activity.
Salas MQ; Ezzat S; Lam W; Law AD; Pasic I; Michelis FV; Kim DDH; Gerbitz A; Al-Shaibani Z; Viswabandya A; Kumar R; Mattsson J; Lipton JH
Article: STEM CELL REVIEWS AND REPORTS. 2021;17(1):63-70
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy.
Berishvili E; Kaiser L; Cohen M; Berney T; Scholz H; Floisand Y; Mattsson J
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(2):179-187
Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option.
Alotaibi AS; Prem S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Mattsson J; Michelis FV
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2021;22(1):169-180
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
Schain F; Batyrbekova N; Liwing J; Baculea S; Webb T; Remberger M; Mattsson J
Article: ACTA HAEMATOLOGICA. 2021;144(1):66-73
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(1):32-39
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
Alblooshi R; Kanfar S; Lord B; Atenafu EG; Michelis FV; Pasic I; Gerbitz A; Al-Shaibani Z; Viswabandya A; Kim DDH; Lam W; Law A; Mattsson J; Kumar R; Lipton JH
Article: BONE MARROW TRANSPLANTATION. 2021;56(1):60-69
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation.
Salas MQ; Atenafu EG; Bascom O; Wilson L; Lam W; Law AD; Pasic I; Kim DDH; Michelis FV; Al-Shaibani Z; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Alibhai SMH; Kumar R
Article: ADVANCES IN THERAPY. 2020;37(12):5023-5031
Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺Expression in Tumor
Magalhaes I; Fernebro J; Abd Own S; Glaessgen D; Corvigno S; Remberger M; Mattsson J; Dahlstrand H
Article: PEDIATRIC TRANSPLANTATION. 2020;24(8):e13824
Diagnostic disagreement between clinical standard histopathological- and retrospective assessment of histopathology-based gastrointestinal graft-versus-host disease in children
Martensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Mattsson J; Gustafsson B; Casswall TH
Article: LEUKEMIA AND LYMPHOMA. 2020;61(13):3198-3208
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis.
Salas MQ; Prem S; Remberger M; Lam W; Kim DDH; Michelis FV; Al-Shaibani Z; Gerbitz A; Lipton JH; Viswabandya A; Kumar R; Kumar D; Mattsson J; Law AD
Article: BONE MARROW TRANSPLANTATION. 2020;55(9):1773-1783
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD.
Salas MQ; Prem S; Atenafu EG; Datt Law A; Lam W; Al-Shaibani Z; Loach D; Kim DDH; Michelis FV; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Article: BLOOD CELL THER. 2020;3(3):48-58
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.
Salas MQ; Atenafu EG; Lam W; Law AD; Kim DDH; Michelis FV; Al-Shaibani Z; Gerbitz A; Lipton JH; Viswabandya A; Mattsson J; Gupta V; Kumar R
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2020;2020:7375947-12
Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins
Foord E; Klynning C; Schoutrop E; Forster JM; Krieg J; Mortberg A; Mueller MR; Herzog C; Schiegg D; Villemagne D; Fiedler U; Snell D; Kebble B; Mattsson J; Levitsky V; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(8):1511-1519
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.
Salas MQ; Chen S; Lam W; Pasic I; Gerbitz A; Michelis FV; Kim DDH; Al-Shaibani Z; Lipton JH; Mattsson J; Kumar R; Viswabandya A; Law AD
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2020;20(8):2198-2205
Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Cheng G-S; Selwa KE; Hatt C; Ram S; Fortuna AB; Guerriero M; Himelhoch B; McAree D; Hoffman TC; Brisson J; Nazareno R; Bloye K; Johnson TD; Remberger M; Mattsson J; Vummidi D; Kazerooni EE; Lama VN; Galban S; Boeckh M; Yanik GA; Galban CJ
Article: ONCOIMMUNOLOGY. 2020;9(1):1792058
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination
Lovgren T; Wolodarski M; Wickstrom S; Edback U; Wallin M; Martell E; Markland K; Blomberg P; Nystrom M; Lundqvist A; Jacobsson H; Ullenhag G; Ljungman P; Hansson J; Masucci G; Tell R; Poschke I; Adamson L; Mattsson J; Kiessling R
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(1):24-29
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
Vasudevan Nampoothiri R; Law AD; Lam W; Chen C; Al-Shaibani Z; Loach D; Michelis FV; Kim DDH; Mattsson J; Kumar R; Lipton JH; Viswabandya A
Article: CLINICAL HEMATOLOGY INTERNATIONAL. 2020;2(2):74-81
The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors.
Remberger M; Grønvold B; Ali M; Mattsson J; Egeland T; Lundin KU; Myhre A; Abrahamsen I; Heldal D; Dybedal I; Tjønnfjord GE; Gedde-Dahl T; Fløisand Y
Article: ANNALS OF HEMATOLOGY. 2020;99(6):1377-1387
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
Pasic I; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Mattsson J; Michelis FV
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2020;111(4):591-594
Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells
Sadeghi B; Ersmark B; Moretti G; Mattsson J; Ringden O
Article: CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(2):293-300
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
El-Serafi I; Remberger M; Ringden O; Torlen J; Sundin M; Bjorklund A; Winiarski J; Mattsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;104(2):116-124
Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survival.
Prem S; Atenafu EG; Lam W; Law A; Michelis FV; Kim D; Viswabandya A; Howard Lipton J; Mattsson J; Kumar R
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;104(1):36-45
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.
Salas MQ; Atenafu EG; Bautista MR; Prem S; Lam W; Datt Law A; Shaibani Z-A; Kim DDH; Michelis FV; Lipton JH; Viswabandya A; Mattsson J; Kumar R
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(6):597-606
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.
Salas MQ; Lam W; Law AD; Kim DDH; Michelis FV; Loach D; Al-Shaibani Z; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(5):483-490
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.
Prem S; Atenafu EG; Avena J; Bautista R; Law A; Lam W; Michelis FV; Kim DDH; Viswabandya A; Lipton JH; Mattsson J; Kumar R
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(5):510-518
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.
Salas MQ; Prem S; Atenafu EG; Law AD; Lam W; Al-Shaibani Z; Loach D; Kim DDH; Michelis FV; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(5):519-522
Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host disease.
Prem S; Al-Shaibani Z; Michelis FV; Kim D; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Law A; Lam W
Article: VOX SANGUINIS. 2019;114(7):769-777
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation
Berglund S; Watz E; Remberger M; Legert KG; Axdorph-Nygell U; Sundin M; Uhlin M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1965-1969
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2019;54(10):1562-1574
T-cell frequencies of CD8⁺ γδ and CD27⁺ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation
Gaballa A; Stikvoort A; Onfelt B; Mattsson J; Sundin M; Watz E; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(9):1761-1769
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease
Shapiro RM; Shin E; Law AD; Lama W; Michelis FV; Viswabandya A; Kumar R; Lipton JH; Messner H; Mattsson J; Kim DDH
Article: CLINICAL HEMATOLOGY INTERNATIONAL. 2019;1(2):105-113
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis.
Salas MQ; Law AD; Lam W; Al-Shaibani Z; Loach D; Kim DDH; Michelis FV; Thyagu S; Kumar R; Lipton JH; Mattsson J; Viswabandya A
Article: CLINICAL TRANSPLANTATION. 2019;33(6):e13537
The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Article: TRANSPLANTATION. 2019;103(6):1247-1252
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor
Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(6):1260-1268
Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Torlen J; Gaballa A; Remberger M; Mork L-M; Sundberg B; Mattsson J; Uhlin M
Article: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 2019;24(5):639-648
Pre-formulation investigations for establishing a protocol for treosulfan handling and activation
El-Serafi I; Loy O; Zhao Y; Oerther S; Mattsson J
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:189
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
Radestad E; Sundin M; Torlen J; Thunberg S; Onfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Article: CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;44(1):84-91
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
Afram G; Watz E; Remberger M; Nygell UA; Sundin M; Hagglund H; Mattsson J; Uhlin M
Article: CYTOTHERAPY. 2018;20(7):941-951
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells
Alnabhan R; Gaballa A; Mork L-M; Mattsson J; Uhlin M; Magalhaes I
Article: TRANSFUSION. 2018;58(6):1442-1451
Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors
Wang T; Remberger M; Nygell UA; Sundin M; Bjorklund A; Mattsson J; Uhlin M; Watz E
Article: SCIENTIFIC REPORTS. 2018;8(1):8293
The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation
El-Serafi I; Remberger M; El-Serafi A; Benkessou F; Zheng W; Martell E; Ljungman P; Mattsson J; Hassan M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2018;107(4):478-485
Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation
Ringden O; Sadeghi B; Moretti G; Finnbogadottir S; Eriksson B; Mattsson J; Svahn B-M; Remberger M
Article: TRANSPLANT INFECTIOUS DISEASE. 2018;20(2):e12847
Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis
Swartling L; Ljungman P; Remberger M; Sundin M; Tiveljung A; Mattsson J; Sparrelid E
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):467-477
Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition
Stikvoort A; Gaballa A; Solders M; Nederlof I; Onfelt B; Sundberg B; Remberger M; Sundin M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOTHERAPY. 2018;41(2):73-83
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN- Production Profile
Magalhaes I; Kalland I; Kochenderfer JN; Osterborg A; Uhlin M; Mattsson J
Article: EUROPEAN JOURNAL OF CANCER CARE. 2018;27(1):e12610
Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study
Bergkvist K; Larsen J; Johansson U-B; Mattsson J; Fossum B
Article: EUROPEAN JOURNAL OF CANCER CARE. 2018;27(1):e12672
Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation
Bergkvist K; Fossum B; Johansson U-B; Mattsson J; Larsen J
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Remberger M; Torlen J; El Serafi I; Garming-Legert K; Bjorklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: ONCOTARGET. 2017;8(36):60257-60269
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
Radestad E; Egevad L; Jorns C; Mattsson J; Sundberg B; Nava S; Ericzon B-G; Henningsohn L; Levitsky V; Uhlin M
Article: CLINICAL TRANSPLANTATION. 2017;31(8)
No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies
Magalhaes I; Uhlin M; Schaffer M; Sundin M; Hauzenberger D; Remberger M; Mattsson J
Article: VOX SANGUINIS. 2017;112(5):459-468
Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation
Nilsson J; Granrot I; Mattsson J; Omazic B; Uhlin M; Thunberg S
Article: JOURNAL OF IMMUNOTHERAPY. 2017;40(4):132-139
A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer
Omazic B; Ayoglu B; Lohr M; Segersvard R; Verbeke C; Magalhaes I; Potacova Z; Mattsson J; Terman A; Ghazi S; Albiin N; Kartalis N; Nilsson P; Poiret T; Liu Z; Heuchel R; Schwenk JM; Permert J; Maeurer MJ; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(4):677-683
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions
Torlen J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Article: PLOS ONE. 2017;12(11):e0187294
Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
El-Serafi I; Terelius Y; Abedi-Valugerdi M; Naughton S; Saghafian M; Moshfegh A; Mattsson J; Potacova Z; Hassan M
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:717
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
Stikvoort A; Chen Y; Radestad E; Torlen J; Lakshmikanth T; Bjorklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Article: HAEMATOLOGICA. 2016;101(11):1417-1425
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1684-1689
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation
Blennow O; Remberger M; Torlen J; Szakos A; Ljungman P; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2016;20(5):667-674
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades
Svenberg P; Remberger M; Uzunel M; Mattsson J; Gustafsson B; Fjaertoft G; Sundin M; Winiarski J; Ringden O
Article: ONCOTARGET. 2016;7(17):23581-23593
Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes
Norstrom MM; Radestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
Article: TRANSPLANT INFECTIOUS DISEASE. 2016;18(2):240-246
Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis
Franzen J; Ramqvist T; Bogdanovic G; Grun N; Mattson J; Dalianis T
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(4):676-681
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer
Omazic B; Remberger M; Barkholt L; Soderdahl G; Potacova Z; Wersall P; Ericzon B-G; Mattsson J; Ringden O
Article: PLOS ONE. 2016;11(5):e0154737
Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?
Stikvoort A; Sundin M; Uzunel M; Gertow J; Sundberg B; Schaffer M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2016;2016:5601204-11
Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Sairafi D; Stikvoort A; Gertow J; Mattsson J; Uhlin M
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(6):785-794
Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients
Swartling L; Allard A; Torlen J; Ljungman P; Mattsson J; Sparrelid E
Article: HAEMATOLOGICA. 2015;100(11):1477-1485
Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy
Nakasone H; Remberger M; Tian L; Brodin P; Sahaf B; Wu F; Mattsson J; Lowsky R; Negrin R; Miklos DB; Meyer E
Article: TRANSFUSION. 2015;55(10):2339-2350
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation
Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
Article: CELL METABOLISM. 2015;22(3):408-417
Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis
Ryden M; Uzunel M; Hard JL; Borgstrom E; Mold JE; Arner E; Mejhert N; Andersson DP; Widlund Y; Hassan M; Jones CV; Spalding KL; Svahn B-M; Ahmadian A; Frisen J; Bernard S; Mattsson J; Arner P
Article: SUPPORTIVE CARE IN CANCER. 2015;23(5):1273-1283
General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care
Bergkvist K; Winterling J; Johansson E; Johansson U-B; Svahn B-M; Remberger M; Mattsson J; Larsen J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(5):889-893
Effect of Total Nucleated and CD34⁺ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
Remberger M; Torlen J; Ringden E; Engstrom M; Watz E; Uhlin M; Mattsson J
Article: CYTOTHERAPY. 2014;16(11):1528-1536
Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation
Berglund S; Gertow J; Uhlin M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(11):1777-1784
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning
Ringden O; Brazauskas R; Wang Z; Ahmed I; Atsuta Y; Buchbinder D; Burns LJ; Cahn J-Y; Duncan C; Hale GA; Halter J; Hayashi RJ; Hsu JW; Jacobsohn DA; Kamble RT; Kamani NR; Kasow KA; Khera N; Lazarus HM; Loren AW; Marks DI; Myers KC; Ramanathan M; Saber W; Savani BN; Schouten HC; Socie G; Sorror ML; Steinberg A; Popat U; Wingard JR; Mattsson J; Majhail NS
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1646-1649
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
Article: PROSTATE. 2014;74(14):1391-1399
Novel Method to Characterize Immune Cells From Human Prostate Tissue
Norstrom MM; Radestad E; Stikvoort A; Egevad L; Bergqvist M; Henningsohn L; Mattsson J; Levitsky V; Uhlin M
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(8):4941-4943
Posaconazole Concentrations in Human Tissues after Allogeneic Stem Cell Transplantation
Blennow O; Eliasson E; Pettersson T; Pohanka A; Szakos A; El-Serafi I; Hassan M; Ringden O; Mattsson J
Article: STEM CELLS AND DEVELOPMENT. 2014;23(14):1559-1567
T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
Article: PEDIATRIC TRANSPLANTATION. 2014;18(4):398-404
Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital
Ringden O; Remberger M; Torlen J; Engstrom M; Fjaertoft G; Mattsson J; Svahn B-M
Article: TRANSPLANT INFECTIOUS DISEASE. 2014;16(2):203-212
Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation
Wikell H; Ponandai-Srinivasan S; Mattsson J; Gertow J; Uhlin M
Article: HAEMATOLOGICA. 2014;99(2):346-352
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2014;16(1):106-114
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(2):264-271
Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning
Watz E; Remberger M; Ringden E; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(1):135-138
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.
Ruutu T; Juvonen E; Remberger M; Remes K; Volin L; Mattsson J; Nihtinen A; Hägglund H; Ringdén O; Nordic Group for Blood and Marrow Transplantation
Article: PLOS ONE. 2014;9(1):e86619
Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation
El-Serafi I; Abedi-Valugerdi M; Potacova Z; Afsharian P; Mattsson J; Moshfegh A; Hassan M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2014;2014:578741-14
Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors
Radestad E; Wikell H; Engstrom M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
Article: CLINICAL DRUG INVESTIGATION. 2014;34(1):43-52
Comparison of Algorithms for Oral Busulphan Area Under the Concentration-Time Curve Limited Sampling Estimate
Sjoo F; El-Serafi I; Enestig J; Mattsson J; Liwing J; Hassan M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(1):128-132
Reduced IL-7 Responsiveness Defined by Signal Transducer and Activator of Transcription 5 Phosphorylation in T Cells May Be a Marker for Increased Risk of Developing Cytomegalovirus Disease in Patients after Hematopoietic Stem Cell Transplantation
Perez-Bercoff L; Vudattu NK; Byrareddy SN; Mattsson J; Maeurer M; Ljungman P
Article: JOURNAL OF IMMUNOTHERAPY. 2013;36(8):432-441
Cord Blood T Cells Cultured With IL-7 in Addition to IL-2 Exhibit a Higher Degree of Polyfunctionality and Superior Proliferation Potential
Berglund S; Gertow J; Magalhaes I; Mattsson J; Uhlin M
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2013;17(4):389-395
Hospital care or home care after allogeneic hematopoietic stem cell transplantation - Patients' experiences of care and support
Bergkvist K; Larsen J; Johansson U-B; Mattsson J; Svahn B-M
Article: NURSING ETHICS. 2013;20(5):528-538
Caring for children in pediatric intensive care units: An observation study focusing on nurses' concerns
Mattsson J; Forsner M; Castren M; Arman M
Article: CLINICAL TRANSPLANTATION. 2013;27(4):E368-E374
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors
Remberger M; Ringden O; Hagglund H; Svahn B-M; Ljungman P; Uhlin M; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2013;17(3):285-293
Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioning
Martensson T; Priftakis P; Casswall T; Ringden O; Mattsson J; Remberger M; Hassan M; Gustafsson B
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(5):838-844
Chimerism Patterns of Long-Term Stable Mixed Chimeras Posthematopoietic Stem Cell Transplantation in Patients with Nonmalignant Diseases: Follow-Up of Long-Term Stable Mixed Chimerism Patients
Stikvoort A; Gertow J; Sundin M; Remberger M; Mattsson J; Uhlin M
Article: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2013;9(4):307-317
Systems level immune response analysis and personalized medicine
Brodin P; Valentini D; Uhlin M; Mattsson J; Zumla A; Maeurer MJ
Article: BONE MARROW TRANSPLANTATION. 2013;48(4):537-543
Graft failure in the modern era of allogeneic hematopoietic SCT
Olsson R; Remberger M; Schaffer M; Berggren DM; Svahn B-M; Mattsson J; Ringden O
Article: STEM CELLS. 2013;31(3):592-601
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(2):314-320
Many Days at Home during Neutropenia after Allogeneic Hematopoietic Stem Cell Transplantation Correlates with Low Incidence of Acute Graft-versus-Host Disease
Ringden O; Remberger M; Holmberg K; Edeskog C; Wikstrom M; Eriksson B; Finnbogadottir S; Fransson K; Milovsavljevic R; Omazic B; Svenberg P; Mattsson J; Svahn B-M
Article: CHIMERISM. 2013;4(1):34-35
Chimerism and use of mesenchymal stem cells in umbilical cord blood transplantation.
Berglund S; Uhlin M; Mattsson J
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2012;96(6):798-800
Major surgery in a neutropenic patient undergoing allogeneic stem cell transplantation for high risk myelofibrosis
Brodin P; Gilg S; Lundell L; Mattsson J
Article: MEDICAL ONCOLOGY. 2012;29(4):2348-2358
Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution
Nahi H; Remberger M; Machaczka M; Ungerstedt J; Mattson J; Ringden O; Le-Blanc K; Ljungman P; Hagglund H
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2012;55(8):1064-1073
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2012;89(3):220-227
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation
Forslow U; Blennow O; LeBlanc K; Ringden O; Gustafsson B; Mattsson J; Remberger M
Article: TRANSPLANT IMMUNOLOGY. 2012;27(1):59-62
Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation
Remberger M; Persson M; Mattsson J; Gustafsson B; Uhlin M
Article: STEM CELLS AND DEVELOPMENT. 2012;21(9):1409-1417
Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation
Uhlin M; Sairafi D; Berglund S; Thunberg S; Gertow J; Ringden O; Uzunel M; Remberger M; Mattsson J
Article: CLINICAL IMMUNOLOGY. 2012;143(2):134-144
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantation
Gertow J; Berglund S; Okas M; Karre K; Remberger M; Mattsson J; Uhlin M
Article: CLINICAL IMMUNOLOGY. 2012;142(3):343-350
Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival
Sairafi D; Mattsson J; Uhlin M; Uzunel M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Ringden O; Remberger M; Dahllof G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: TRANSPLANT IMMUNOLOGY. 2011;25(2-3):153-158
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation
Nordlander A; Uhlin M; Ringden O; Kumlien G; Hauzenberger D; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(8):1214-1221
Donor Lymphocyte Infusion May Reduce the Incidence of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation
Forslow U; Mattsson J; Gustafsson T; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2011;46(5):719-726
Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT
Tobiasson M; Olsson R; Hellstrom-Lindberg E; Mattsson J
Article: PEDIATRIC BLOOD AND CANCER. 2011;56(3):444-451
Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
Carlsson G; Winiarski J; Ljungman P; Ringden O; Mattsson J; Nordenskjold M; Touw I; Henter J-I; Palmblad J; Fadeel B; Hagglund H
Article: CLINICAL TRANSPLANTATION. 2011;25(1):E68-E76
Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure
Remberger M; Mattsson J; Olsson R; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2010;45(12):1710-1718
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2010;16(12):1728-1737
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
Sairafi D; Remberger M; Uhlin M; Ljungman P; Ringden O; Mattsson J
Article: TRANSPLANTATION. 2010;90(9):1022-1029
Granulocyte Colony-Stimulating Factor Induced Acute and Chronic Graft-Versus-Host Disease
Ringden O; Hassan Z; Karlsson H; Olsson R; Omazic B; Mattsson J; Remberger M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2010;162(1):146-155
Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation
Gertow J; Berglund S; Okas M; Uzunel M; Berg L; Karre K; Mattsson J; Uhlin M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2010;92(1):161-167
C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation
Remberger M; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2010;45(5):945-950
The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia
Forslow U; Remberger M; Nordlander A; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2010;45(4):682-688
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit
Gilli K; Remberger M; Hjelmqvist H; Ringden O; Mattsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2010;84(4):323-331
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants
Olsson R; Remberger M; Hassan Z; Omazic B; Mattsson J; Ringden O
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2010;59(3):473-477
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
Uhlin M; Okas M; Gertow J; Uzunel M; Brismar TB; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2010;45(2):235-238
Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Mattsson J; Nordlander A; Remberger M; Uhlin M; Holgersson J; Ringden O; Hauzenberger D
Article: JOURNAL OF IMMUNOTHERAPY. 2010;33(1):96-105
Clinical Expansion of Cord Blood-derived T Cells for Use as Donor Lymphocyte Infusion After Cord Blood Transplantation
Okas M; Gertow J; Uzunel M; Karlsson H; Westgren M; Karre K; Ringden O; Mattsson J; Uhlin M
Article: BONE MARROW TRANSPLANTATION. 2009;44(11):757-763
Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism
Svenberg P; Mattsson J; Ringden O; Uzunel M
Article: TRANSPLANTATION. 2009;88(10):1222-1226
Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2009;90(4):526-531
Stable mixed donor-donor chimerism after double cord blood transplantation
Berglund S; Okas M; Gertow J; Uhlin M; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: TRANSPLANTATION. 2009;87(4):467-472
Increased Frequency and Responsiveness of PSA-Specific T Cells After Allogeneic Hematopoetic Stem-Cell Transplantation
Uhlin M; Okas M; Karlsson H; Gertow J; Henningsohn L; Ringden O; Karre K; Levitsky V; Mattsson J
Article: HLA. 2008;72(6):549-558
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study
Hauzenberger D; Schaffer M; Ringden O; Hassan Z; Omazic B; Mattsson J; Wikstrom A-C; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2008;42(10):643-648
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor
Ringden O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Article: TRANSPLANTATION. 2008;86(5):686-696
Novel antibodies to the donor stem cell population CD34⁺/VEGFR-2⁺ are associated with rejection after hematopoietic stem cell transplantation
Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
Article: BONE MARROW TRANSPLANTATION. 2008;41(11):961-964
No impact of NOD2/CARD15 on outcome after SCT
Sairafi D; Uzunel M; Remberger M; Ringden O; Mattsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2008;80(5):419-428
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia
Remberger M; Mattsson J; Hausenberger D; Schaffer M; Svahn B-M; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2008;41(9):785-790
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation
Barkholt L; Remberger M; Hassan Z; Fransson K; Omazic B; Svahn B-M; Karlsson H; Brune M; Hassan M; Mattsson J; Ringden O
Article: TRANSPLANTATION. 2008;85(7):1000-1007
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation:: The role of oral nutrition
Svahn B-M; Remberger M; Heijbel M; Martell E; Wikstrom M; Eriksson B; Milovsavljevic R; Mattsson J; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2008;41(8):737-742
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts
Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2008;41(3):267-273
Allogeneic stem cell transplantation:: low immunoglobulin levels associated with decreased survival
Norlin A-C; Sairafi D; Mattsson J; Ljungman P; Ringden O; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2008;41(4):399-405
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors -: a single centre study
Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(1):165-170
Graft failure after allogeneic hematopoietic cell transplantation
Mattsson J; Ringden O; Storb R
Article: CLINICAL TRANSPLANTATION. 2007;21(5):659-667
Hemorrhagic cystitis:: a retrospective single-center survey
Hassan Z; Remberger M; Svenberg P; Elbander M; Omazic B; Mattsson J; Conrad R; Svahn B-M; Ahlgren A; Sairafi D; Aschan J; Le Blanc K; Barkholt L; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(6):675-682
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation
Remberger M; Watz E; Ringdén O; Mattsson J; Shanwell A; Wikman A
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2006;38(9):629-633
Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease
Mattsson J; Westin S; Edlund S; Remberger M
Article: TRANSPLANTATION. 2006;82(7):913-919
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning
Uzunel M; Remberger M; Sairafi D; Hassan Z; Mattsson J; Omazic B; Barkholt L; Ringden O
Article: TRANSPLANTATION. 2006;81(5):718-725
Allogeneic hematopoietic stem cell transplantation for inherited disorders:: Experience in a single center
Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2006;38(11-12):970-976
Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation
Forslow U; Mattsson J; Ringden O; Klominek J; Remberger M
Article: FETAL DIAGNOSIS AND THERAPY. 2005;20(5):355-358
Identification of maternal hematopoietic cells in a 2nd-trimester fetus
Götherström C; Johnsson AM; Mattsson J; Papadogiannakis N; Westgren M
Article: CLINICAL TRANSPLANTATION. 2005;19(3):346-349
Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV
Jaksch M; Uzunel M; Remberger M; Sundberg B; Mattsson J
Article: TRANSPLANTATION. 2005;79(10):1411-1416
Decreased serum levels of Clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation
Mattsson J; Remberger M; Andersson O; Sundberg B; Nord M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2005;11(4):280-287
Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation
Jaksch M; Remberger M; Mattsson J
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;61(3):285-294
T-cell receptor Vβ repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation
Hentschke P; Omazic B; Mattsson J; Näsman-Björk I; Lundkvist I; Gigliotti D; Barkholt L; Ringdén O; Remberger M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;61(1):72-81
Reconstitution of the ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens
Omazic B; Hentschke P; Näsman-Björk I; Mattsson J; Oxelius VA; Ringdén O; Barkholt L; Permert J; Lundkvist I
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(12):877-882
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors
Svenberg P; Remberger M; Svennilson J; Mattsson J; Leblanc K; Gustafsson B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Ringdén O
Article: TRANSPLANTATION. 2004;78(7):1014-1020
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
Le Blanc K; Remberger M; Uzunel M; Mansson J; Barkholt L; Ringdén O
Article: TRANSPLANTATION. 2004;78(1):154-157
Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation
Mattson J; Jansson M; Wernerson A; Hassan M
Article: TRANSPLANTATION. 2004;78(1):122-127
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation
Remberger M; Svahn BM; Mattsson J; Ringdén O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(3):195-203
Graft-versus-Host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Article: TRANSPLANTATION. 2004;77(2):195-200
Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantation
Jaksch M; Remberger M; Mattsson J
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003;134(1):159-166
Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantation
Omazic B; Lundkvist I; Mattsson J; Permert J; Näsman-Björk I
Article: BONE MARROW TRANSPLANTATION. 2003;32(5):477-483
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Hassan M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;122(5):788-794
Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia
Uzunel M; Jaksch M; Mattsson J; Ringdén O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2003;70(6):384-391
Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation
Remberger M; Jaksch M; Uzunel M; Mattsson J
Article: TRANSPLANTATION. 2003;75(7):1061-1066
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans
Söderdahl G; Barkholt L; Hentschke P; Mattsson J; Uzunel M; Ericzon BG; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2003;31(3):183-190
Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation
Jaksch M; Uzunel M; Cangana GM; Remberger M; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2003;31(4):253-261
Reduced intensity conditioning regimens -: Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma
Hentschke P; Barkholt L; Uzunel M; Mattsson J; Wersäll P; Pisa P; Martola J; Albiin N; Wernerson A; Söderberg M; Remberger M; Thörne A; Ringdén O
Article: BLOOD. 2003;101(2):469-472
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
Uzunel M; Mattsson J; Brune M; Johansson JE; Aschan J; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;119(4):1133-1136
The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation
Nordlander A; Uzunel M; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2002;30(11):761-768
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors
Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2002;187(2):475-482
Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency
Westgren M; Ringdén O; Bartmann P; Bui TH; Lindton B; Mattsson J; Uzunel M; Zetterquist H; Hansmann M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2002;119(1):240-249
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT)
Björk IN; Brissac C; Remberger M; Mattsson J; Klaesson S; Ringdén O; Stewart J; Lundkvist I
Article: TRANSPLANTATION. 2002;73(6):930-936
Clinical tolerance after allogeneic hematopoietic stem cell transplantation -: A study of influencing factors
Hentschke P; Remberger M; Mattsson J; Barkholt L; Aschan J; Ljungman P; Ringdén O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2002;8(12):674-682
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Remberger M; Kumlien G; Aschan J; Barkholt L; Hentschke P; Ljungman P; Mattsson J; Svennilson J; Ringdén O
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001;123(1):162-169
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;115(4):935-944
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation
Mattsson J; Uzunel M; Brune M; Hentschke P; Barkholt L; Stierner U; Aschan J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2001;28(12):1161-1166
A graft-versus-colonic cancer effect of allogeneic stem cell transplantation
Zetterquist H; Hentschke P; Thörne A; Wernerson A; Mattsson J; Uzunel M; Martola J; Albiin N; Aschan J; Papadogiannakis N; Ringdén O
Article: LEUKEMIA. 2001;15(12):1976-1985
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Tammik L; Aschan J; Ringdén O
Article: BLOOD. 2001;98(6):1982-1984
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
Uzunel M; Mattsson J; Jaksch M; Remberger M; Ringdén O
Article: PEDIATRIC TRANSPLANTATION. 2001;5(4):285-292
Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation
Remberger M; Mattsson J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2001;27(11):1163-1171
Altered expression of receptors for thyroid hormone and insulin-like growth factor-1 during reconstitution after allogeneic hematopoietic stem cell transplantation
Omazic B; Näsman-Björk I; Johansson J; Hentschke P; Mattsson J; Permert J; Lundkvist I
Article: TRANSPLANTATION. 2001;71(3):433-439
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Ringdén O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(1):50-56
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation
Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Article: TRANSPLANTATION. 2000;69(10):2043-2048
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer
Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
Article: BONE MARROW TRANSPLANTATION. 2000;25(9):993-996
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation
Ringdén O; Remberger M; Lehmann S; Hentschke P; Mattsson J; Klaesson S; Aschan J
Article: BONE MARROW TRANSPLANTATION. 2000;25(8):843-851
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Article: LEUKEMIA. 2000;14(2):247-254
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease
Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Article: CLINICAL TRANSPLANTATION. 1999;13(6):512-519
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease:: a long-term follow-up
Aschan J; Carlens S; Hägglund H; Klaesson S; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 1999;24(9):1033-1035
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients
Hentschke P; Hägglund H; Mattsson J; Carlens S; Lönnqvist B; Ljungman P; Aschan J; Fredrikson S; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1999;24(8):831-836
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation
Hägglund H; Ringdén O; Öman S; Remberger M; Carlens S; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 1999;24(3):279-282
Unrelated donor stem cell transplantation after autologous transplantation:: experience of a single center
Aschan J; Remberger M; Carlens S; Mattsson J; Dilber MS; Lönnqvist B; Björkstrand B
Article: TRANSPLANTATION. 1998;66(10):1330-1334
Results of different strategies for reducing:: Cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):755-761
Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Article: TRANSPLANTATION. 1998;66(5):620-625
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including, anti-T-cell antibodies
Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
Article: PEDIATRIC TRANSPLANTATION. 1998;2(2):150-156
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Article: CLINICAL TRANSPLANTATION. 1998;12(2):84-92
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination
Carlens S; Ringden O; Aschan J; Hagglund H; Ljungman P; Mattsson J; Remberger M
Article: BONE MARROW TRANSPLANTATION. 1998;21(1):43-49
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age
Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Visa fler

Alla övriga publikationer

Letter: INTENSIVE CARE MEDICINE. 2023;49(12):1552-1554
Decidual stromal cells for the treatment of severe COVID-19 ARDS.
Granton J; Novitzky-Basso IN; Binnie A; Mattsson J; DSC Study Group
Review: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2023;118(1):1-17
Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy.
Al-Shaibani E; Novitzky-Basso I; Mattsson J; Kim DDH
Other: IDCASES. 2022;29:e01608
Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation.
Pang I; Singhabahu S; Novitzky-Basso I; Mazzulli T; Husain S; Mattsson J
Letter: BONE MARROW TRANSPLANTATION. 2021;56(3):689-691
Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies.
Prem S; Remberger M; Salas MQ; Al-Shaibani Z; Lam W; Law AD; Kim DDH; Michelis FV; Lipton JH; Mattsson J; Kumar R; Ellison C; Viswabandya A
Review: EXPERT REVIEW OF HEMATOLOGY. 2020;13(10):1119-1130
Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review
Csanadi M; agh T; Farkas-Raduly S; Gros B; Tapprich C; Trudeau JJ; Lipton JH; Mattsson J
Letter: BONE MARROW TRANSPLANTATION. 2020;55(8):1658-1661
HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation.
Grønvold B; Ali MM; Remberger M; Mattsson J; Egeland T; Lundin KU; Myhre AE; Abrahamsen IW; Heldal D; Dybedal I; Tjønnfjord GE; Fløisand Y; Gedde-Dahl T
Other: CASE REPORTS IN IMMUNOLOGY. 2020;2020:9403123-4
Posttransplantation Lymphoproliferative Disease Treated by Retransplantation.
Weum Abrahamsen I; Grønvold BC; Inderberg EM; Mensali N; Mattsson J; Gedde-Dahl T
Review: EXPERT OPINION ON BIOLOGICAL THERAPY. 2019;19(8):811-827
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer.
Magalhaes I; Carvalho-Queiroz C; Hartana CA; Kaiser A; Lukic A; Mints M; Nilsson O; Grönlund H; Mattsson J; Berglund S
Review: EXPERT REVIEW OF HEMATOLOGY. 2019;12(5):311-323
A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease
Csanadi M; Agh T; Tordai A; Webb T; Jeyakumaran D; Sengupta N; Schain F; Mattsson J
Review: EXPERT REVIEW OF HEMATOLOGY. 2019;12(5):295-309
Humanistic burden of patients with chronic graft-versus-host disease-systematic literature review of health-related quality of life and functional status
Agh T; Csanadi M; Voko Z; Webb T; Jeyakumaran D; Trudeau J; Sengupta N; Schain F; Mattsson J
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(4):720-727
Safety and Effectiveness of Vedolizumab in Patients with Steroid- Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
Floisand Y; Lazarevic VL; Maertens J; Mattsson J; Shah NN; Zachee P; Taylor A; Akbari M; Quadri S; Parfionovas A; Chen Y-B
Review: IMMUNOTHERAPY. 2019;11(4):335-345
Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors
Schurich A; Magalhaes I; Mattsson J
Review: FRONTIERS IN IMMUNOLOGY. 2019;10:2309
The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity
Magalhaes I; Yogev O; Mattsson J; Schurich A
Other: LAKARTIDNINGEN. 2018;115:E6CC
Replik gällande granulocyttransfusion: - Rekommendationerna är väl underbyggda.
Berlin G; Cherif H; Knutson F; Mattsson J; Axdorph Nygell U
Published conference paper: BONE MARROW TRANSPLANTATION. 2018;53(1):69-77
Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients
Gaballa A; Norberg A; Stikvoort A; Mattsson J; Sundberg B; Uzunel M; Remberger M; Uhlin M
Letter: BONE MARROW TRANSPLANTATION. 2016;51(11):1518-1521
High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis
Remberger M; Afram G; Sundin M; Uhlin M; LeBlanc K; Bjorklund A; Mattsson J; Ljungman P
Letter: BONE MARROW TRANSPLANTATION. 2015;50(7):1007-1009
Bone marrow aspiration technique has deteriorated in recent years
Remberger M; Ringden O; Mattsson J
Letter: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(6):1145-1146
Reply to: Transient Grades Three to Four Acute Hepatitis Is a Common Complication of Rabbit Antithymocyte Globulin (Thymoglobulin) Administered before Allogeneic Stem Cell Transplantation
Remberger M; Mattsson J
Letter: TRANSPLANTATION. 2014;98(12):e95-e96
Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease
Maeurer M; Magalhaes I; Andersson J; Ljungman P; Sandholm E; Uhlin M; Mattsson J; Ringden O
Letter: BONE MARROW TRANSPLANTATION. 2014;49(3):463-464
Splenectomy prior to allogeneic hematopoietic SCT increases the risk of post- transplant lymphoproliferative disease
Uhlin M; Norstrom MM; Mattsson J; Remberger M
Corrigendum: PLOS ONE. 2014;9(3):e93239
Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation (vol 9, e86619, 2014)
El-Serafi I; Abedi-Valugerdi M; Potacova Z; Afsharian P; Mattsson J
Letter: BONE MARROW TRANSPLANTATION. 2013;48(12):1583-1584
Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV
Blennow O; Mattsson J; Remberger M
Review: CURRENT OPINION IN PULMONARY MEDICINE. 2012;18(3):264-270
Update on viral infections in lung transplantation
Uhlin M; Mattsson J; Maeurer M
Letter: BONE MARROW TRANSPLANTATION. 2011;46(7):1018
Standardization of Aspergillus PCR is needed
Blennow O; Mattsson J
Editorial comment: IMMUNOTHERAPY. 2011;3(2):131-133
In vitro or in vivo expansion before adoptive T-cell therapy?
Uhlin M; Mattsson J
Letter: BONE MARROW TRANSPLANTATION. 2009;44(12):825-826
Ethmoiditis-associated apex syndrome may result in temporary blindness after allo-SCT
Olsson R; Juto J-E; Mattsson J
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):85
INCREASED FREQUENCY AND RESPONSIVENESS OF PSA-SPECIFIC T CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR PROSTATE CANCER
Mattsson J; Okas M; Ringden O; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):114
STABLE MIXED DONOR-DONOR CHIMERISM AFTER DOUBLE CORD BLOOD TRANSPLANTATION
Gertow J; Berglund S; Okas M; Ringden O; Ublin M; Mattsson J
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):59
GVHD PROPHYLAXIS USING LOW-DOSE CYCLOSPORINE IS SAFE AND REDUCES THE RISK OF RELAPSE AND DEATH IN LEUKEMIC RECIPIENTS OF HLA-IDENTICAL SIBLING TRANSPLANTS
Olsson R; Remberger M; Mattsson J; Hassan Z; Ringden O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):46
TREATMENT OF THREATENING REJECTION AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITH EX VIVO EXPANDED CB DERIVED T CELLS
Uhlin M; Okas M; Gertow J; Ringden O; Mattsson J
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):130-131
CLINICAL EXPANSION OF CORD BLOOD DERIVED T CELLS FOR USE AS DONOR LYMPHOCYTE INFUSION AFTER CORD BLOOD TRANSPLANTATION
Okas M; Gertow J; Uzunel M; Karlsson H; Uzunel M; Ringden O; Mattsson J; Ublin M
Letter: BONE MARROW TRANSPLANTATION. 2008;42(11):769-771
Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose
Remberger M; Mattsson J; Svahn B-M; Ringden O
Review: CURRENT OPINION IN MOLECULAR THERAPEUTICS. 2008;10(4):343-349
Recent progress in allogeneic stem cell transplantation
Mattsson J
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):144
MINIMAL RESIDUAL DISEASE AND CHIMERISM IN CML PATIENTS RECEIVING ALLOGENEIC TRANSPLANTS AFTER MYELOABLATIVE OR REDUCED CONDITIONING
Uzunel M; Mattsson J; Hauzenberger D; Ringden O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):46
CLINICAL ISOLATION AND EX VIVO CULTURING OF CORD BLOOD-DERIVED T CELLS FOR DONOR LYMPHOCYTE INFUSION
Uhlin M; Ringden O; Mattson J
Meeting abstract: BLOOD. 2007;110(11):2969-872A
Prospecitve quantitative PCR monitoring of allogeneic stem cell transplant (SCT) patients at high risk for EBV associated PTLD
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski JH; Yun Z; Ljungman PT
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):97
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation
Remberger M; Watz E; Ringden O; Mattsson J; Shanwell A; Wikman A
Letter: BONE MARROW TRANSPLANTATION. 2006;38(4):321-322
Myeloablative conditioning for hematopoietic stem cell transplantation in patients with non-malignant diseases
Ringden O; Svenberg P; Le Blanc K; Mattsson J; Remberger M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):126
Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single-center
Mattson J; Remberger M; Svahn BM; Svenberg P; Winiarski J; Ringden O
Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;61(5):398-409
The pathophysiology of acute graft-versus-host disease
Jaksch M; Mattsson J
Thesis / dissertation: 2001
Molecular monitoring of engraftment and leukemia relapse after allogeneic hematopoietic stem cell transplantation
Mattsson, Jonas
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1862-1864
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation
Barkholt L; Hentschke P; Zetterquist H; Mattsson J; Uzunel M; Wersäll P; Martola J; Albin N; Aschan J; Wijkström H; Tillegård A; Öman S; Wernerson A; Niederwieser D; Thörne A; Ringdén O
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1769-1770
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation
Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Meeting abstract: GASTROENTEROLOGY. 2000;118(4):A1414
Tumor reduction surgery followed by allogeneic stem cell transplantation. A treatment for disseminated gastrointestinal cancer?
Thorne A; Zetterquist H; Hentchke P; Mattsson J; Uzunel M; Aschan J; Ohman S; Ringden O
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3147-3149
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia
Carlens S; Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3145-3146
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age
Ringden O; Remberger M; Mattsson J; Aschan J; Hagglund H; Carlens S; Lonnqvist B; Sparrelid E; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):735-736
A low incidence of grade II to IV acute GVHD, but high mortality from, infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate
Mattsson J; Ringden O; Aschan J; Barkholt L; Dalianis T; Hagglund H; Ljungman P; Lonnqvist B; Tollemar J; Winiarski J; Remberger M
Visa fler

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2024-2024

Examina och utbildning

Docent, Transplantationsforskning, Karolinska Institutet, 2005
MEDICINE DOKTORSEXAMEN, Institutionen för laboratoriemedicin, Karolinska Institutet, 2001
Läkarexamen, Karolinska Institutet, 1995

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI